Skip to content
★ Sign in to follow
CR

Christina Rubenhag

Boule Diagnostics AB
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€48k
▼ Sales (0 ops.)
—

Latest filing published 28 Sept 2019 for Boule Diagnostics AB, €3,297.

Filing timeline

BuySale
Christina Rubenhag

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Christina Rubenhag: trading record in brief

Christina Rubenhag is a declared insider of Boule Diagnostics AB, with filings sourced from Finansinspektionen. We count 5 filings; the first trade dates from 11 December 2017 and the latest from 26 September 2019.

No open-market sale appears; the market trades are 5 purchases worth €48k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2019: 4 purchases and no sales on the market.

A typical purchase (the median) is worth €9,477. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 28 September 2019 came the latest disclosure, an open-market purchase for €3,297 in Boule Diagnostics AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Christina Rubenhag

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    CfoExecutivesBoule Diagnostics AB
    35,160 SEK35FI-SE
    800 shares@ SEK 43.959.2% of flowAktieISIN SE0000437402FI:csv-f0502c7baf7405ad7902
    Canonical exit: 25 Dec 2019 (T+90)
  • ▲
    CFOExecutivesBoule Diagnostics AB
    84,772 SEK0FI-SE
    77,065 shares@ SEK 1.1022.1% of flowTeckningsoptionFI:csv-c57aeb2b24db35172993
    Canonical exit: 23 Dec 2019 (T+90)
  • ▲
    CFOExecutivesBoule Diagnostics AB
    101,550 SEK34FI-SE
    2,500 shares@ SEK 40.6226.3% of flowAktieISIN SE0011231158FI:csv-83aed386843d85682b3f
    Canonical exit: 13 Nov 2019 (T+90)
  • ▲
    CFOExecutivesBoule Diagnostics AB
    122,000 SEK0FI-SE
    2,000 shares@ SEK 61.00AktieISIN SE0011231158FI:csv-d951ee18a11a3a0d2ff4
    Canonical exit: 9 May 2019 (T+90)
  • ▲
    CFOExecutivesBoule Diagnostics AB
    152,100 SEK23FI-SE
    9,000 shares@ SEK 16.9042.4% of flowFI:csv-c4f1d72b80686df3ea40
    Canonical exit: 11 Mar 2018 (T+90)

5 of 5 declarations